Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000017.xml
Exp Clin Endocrinol Diabetes 1990; 96(6): 325-327
DOI: 10.1055/s-0029-1211028
DOI: 10.1055/s-0029-1211028
Short Communication
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York
11β-Hydroxyandrostenedione in Human Amniotic Fluid
Further Information
Publication History
1989
Publication Date:
16 July 2009 (online)
Summary
11β-Hydroxyandrostene-3,17-dione (11β-hydroxyandrostenedione), a potential marker for prenatal diagnosis of CAH, has been for the first time determined in amniotic fluid obtained from 68 women who later delivered children without endocrine disorders. Its concentration averaged 0.96 ± 0.31 (S.D.) (range 0.48—1.85) nmol/1 and did not depend on the fetal sex. There was mild, insignificant increase of these values along with duration of pregnancy.
Key words
11β-Hydroxandrostenedione - Amniotic fluid